| Literature DB >> 28496419 |
Giannakopoulos Konstantinos1, Ibrahim El-Battrawy1,2, Katja Schramm1, Ansari Uzair1, Ursula Hoffmann1, Borggrefe Martin1,2, Akin Ibrahim1,2.
Abstract
Background: Previous studies revealed that takotsubo cardiomyopathy (TTC) is triggered by physical and emotional stresses. This study was performed to determine the short- and long-term prognostic impact of emotional- and physical stress associated with TTC. Methods and results: Our institutional database constituted a collective of 84 patients diagnosed with TTC between 2003 and 2015. The patients were divided into two groups as per the presence of emotional stress (n = 24, 21%) or physical stress (n = 60, 52.6%). The endpoint was a composite of in-hospital events (thromboembolic events and life-threatening arrhythmias), myocardial infarction, all-cause of mortality, re-hospitalization due to heart failure, stroke, and recurrence of TTC. A Kaplan-Meier analysis indicated a significantly lower event-free survival rate over a mean follow-up of 5 years in the emotional group than the physical stress group (log-rank, p < 0.01). Multivariate Cox regression analysis revealed only emotional stress (HR 0.4, 95% CI: 0.2-0.9, p < 0.05) as a negative independent predictor of the primary endpoint.Entities:
Keywords: emotional stress; mortality; physical stress; prognosis; takotsubo cardiomyopathy
Year: 2017 PMID: 28496419 PMCID: PMC5406392 DOI: 10.3389/fpsyg.2017.00527
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Baseline characteristics of 84 patients initially presenting with takotsubo cardiomyopathy (TTC).
| Variables | Emotional stress ( | Physical stress ( | |
|---|---|---|---|
| Age, mean ± SD | 67.46 ± 8.70 | 67.60 ± 11.78 | 0.95 |
| Female, | 23 (95.83) | 47 (78.33) | |
| Male | 1 (4.16) | 13 (21.66) | |
| Dyspnoe | 2 (8.33) | 32 (53.33) | |
| Chest pain | 17 (70.83) | 22 (36.66) | |
| Systolic BP, mmHg | 135.80 ± 27.97 | 129.87 ± 31.79 | 0.46 |
| Diastolic BP, mmHg | 82.08 ± 13.97 | 76.05 ± 16.33 | 0.25 |
| Heart rate, bpm | 89.90 ± 26.05 | 107.31 ± 28.22 | |
| ST-segment elevation | 6 (25.00) | 16 (26.66) | 0.87 |
| Inversed T-Waves | 20 (83.33) | 53 (88.33) | 1.00 |
| PQ-interval | 158.60 ± 26.27 | 155.46 ± 31.28 | 0.69 |
| QTc (ms), mean ± SD | 488.05 ± 57.91 | 477.24 ± 50.30 | 0.42 |
| Troponin I (U/L) | 1.61 ± 1.24 | 4.04 ± 5.73 | |
| Creatine phosphokinase (U/L) | 365.18 ± 938.50 | 957.14 ± 3562.46 | 0.44 |
| Creatine phosphokinase myocard type | 19.29 ± 18.98 | 37.61 ± 70.68 | 0.50 |
| C-Reactive protein (mg/l) | 13.71 ± 15.21 | 74.38 ± 97.54 | |
| Hemoglobin | 12.79 ± 1.41 | 11.73 ± 2.28 | |
| Creatinine (mg/dl) | 0.97 ± 0.38 | 1.21 ± 0.75 | 1.00 |
| LV EF % | 38.67 ± 8.61 | 38.72 ± 9.60 | 0.98 |
| LV EF% at follow-up | 52.30 ± 1.70 | 54.1 ± 1.40 | 1.00 |
| RV-involvement | 5 (20.8) | 14 (23) | 1.00 |
| Apical ballooning | 17 (70.83) | 42 (70.00) | 0.88 |
| Mitral regulation | 13 (54.16) | 27 (45.00) | 0.44 |
| Tricspid regulation | 11 (45.83) | 23 (38.33) | 0.52 |
| Smoking | 7 (29.16) | 19 (31.66) | 0.82 |
| Diabetes mellitus | 7 (29.16) | 13 (21.66) | 0.46 |
| Obesity (BMI > 25 kg/m2) | 8 (33.33) | 11 (18.33) | 0.18 |
| Hypertension | 15 (62.50) | 33 (55.00) | 0.53 |
| COPD | 2 (8.33) | 14 (23.33) | 0.13 |
| Atrial fibrillation | 4 (16.66) | 11 (18.33) | 1.00 |
| Coronary artery disease | 7 (29.16) | 9 (15.00) | 0.13 |
| History of malignancy | 2 (8.33) | 10 (16.66) | 0.49 |
| Beta-blocker | 10 (41.66) | 15 (25.00) | 0.18 |
| ACE inhibitor | 8 (33.33) | 17 (28.33) | 0.80 |
| ARB | 3 (12.50) | 5 (8.33) | 0.69 |
| Digitalis | 0 (0) | 1 (1.66) | 1.00 |
| ASS | 7 (29.16) | 14 (23.33) | 0.70 |
| Anticoagulation | 1 (4.16) | 3 (5.00) | 1.00 |
In-hospital events and treatment strategy.
| Variables | Emotional stress ( | Physical stress ( | |
|---|---|---|---|
| Life-threatening arrhythmia | 1 (4.16) | 8 (13.33) | 0.43 |
| NPPV and intubation | 3 (12.50) | 28 (46.66) | |
| Inotropic agents | 2 (8.33) | 14 (23.33) | 0.13 |
| Resuscitation | 1 (4.1) | 6 (10) | 0.66 |
| Defibrillator-Implantation | 1 (4.16) | 0 (0) | 0.28 |
| VA-ECMO | 0 (0) | 1 (1.6) | 1.00 |
| Admission to ICU, length of stay | 2.83 ± 2.01 | 6.02 ± 8.28 | |
| In-hospital death | 0 (0) | 6 (10) | 0.17 |
| Thromboembolic events | 1 (4.16) | 10 (16.66) | 0.16 |
| Acquired Long QTs | 13 (54.16) | 41 (68.33) | 0.27 |
| Cardiogenic Shock | 2 (8.33) | 14 (23.33) | 0.20 |
Multivariate analysis for the composite endpoint.
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | |||
| Age | 1.01 | 0.9–1.0 | 0.30 | |||
| Male | 2.28 | 1.1–4.5 | 2.51 | 1.1–5.4 | ||
| Coronary artery disease | 1.44 | 0.8–2.7 | 0.25 | |||
| Apical ballooning | 1.85 | 0.9–3.7 | 1.54 | 0.7–3.1 | 0.23 | |
| EF ≤ 35% | 2.54 | 1.4–4.4 | 1.79 | 0.9–3.3 | ||
| Atrial fibrillation | 2.00 | 1.1–3.6 | 2.08 | 1.0–4.2 | ||
| Emotional stress | 0.42 | 0.2–0.9 | 0.43 | 0.2–0.9 | ||
| Physical stress | 1.52 | 0.8–2.9 | 0.15 | |||
| Hypertension | 0.92 | 0.5–1.6 | 0.78 | |||
| Diabetes mellitus | 1.10 | 0.6–2.0 | 0.74 | |||
| History of cancer | 2.23 | 1.2–4.3 | 1.03 | 0.4–2.3 | 0.96 | |